Related references
Note: Only part of the references are listed.Nuclear factor kappa B-mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice
Jessica Lo et al.
HEPATOLOGY (2015)
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy
Randy J. Chandler et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I
Pedro Berraondo et al.
JOURNAL OF HEPATOLOGY (2015)
Adeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics
Jun Xie et al.
SEMINARS IN LIVER DISEASE (2015)
Prognosis of Untreated Hepatocellular Carcinoma
Edoardo G. Giannini et al.
HEPATOLOGY (2015)
Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin
Buyun Ma et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Adeno-Associated Virus Vectors and Neurological Gene Therapy
David S. Ojala et al.
NEUROSCIENTIST (2015)
Targeting Gene-Virus-Mediated Manganese Superoxide Dismutase Effectively Suppresses Tumor Growth in Hepatocellular Carcinoma In Vitro and In Vivo
Fang Huang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
T. Du et al.
CANCER GENE THERAPY (2014)
Selective In Vivo Targeting of Human Liver Tumors by Optimized AAV3 Vectors in a Murine Xenograft Model
Chen Ling et al.
HUMAN GENE THERAPY (2014)
Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy
Jheel Pandya et al.
IMMUNOLOGY AND CELL BIOLOGY (2014)
Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
Li Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials
Bruna Scaggiante et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
SMAC-armed vaccinia virus induces both apoptosis and necroptosis and synergizes the efficiency of vinblastine in HCC
Qiang Pan et al.
HUMAN CELL (2014)
Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera)
Florence Salmon et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Immune responses to AAV-vectors, the Glybera example from bencn to bedside
Valerie Ferreira et al.
FRONTIERS IN IMMUNOLOGY (2014)
Trial Watch Oncolytic viruses for cancer therapy
Jonathan Pol et al.
ONCOIMMUNOLOGY (2014)
Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model
Wen Lei et al.
ACTA PHARMACOLOGICA SINICA (2013)
Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo
Liujiang Song et al.
CYTOTHERAPY (2013)
Systemic Image-Guided Liver Cancer Radiovirotherapy Using Dendrimer-Coated Adenovirus Encoding the Sodium Iodide Symporter as Theranostic Gene
Geoffrey K. Gruenwald et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa
Anurag Sharma et al.
PLOS ONE (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma
Lijie Yuan et al.
TUMOR BIOLOGY (2013)
Prospects for oral replicating adenovirus-vectored vaccines
Cailin Deal et al.
VACCINE (2013)
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
Ying Zhou et al.
BMC CANCER (2012)
Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL
X. Liu et al.
CANCER GENE THERAPY (2012)
Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
Iulia Diaconu et al.
CANCER RESEARCH (2012)
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
J. D. Dias et al.
GENE THERAPY (2012)
Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth
Guoqing He et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Polymer coatings for delivery of nucleic acid therapeutics
Richard Laga et al.
JOURNAL OF CONTROLLED RELEASE (2012)
An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
Vincenzo Cerullo et al.
MOLECULAR THERAPY (2012)
Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma
Kang-Jian Zhang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?
Luc J. W. van der Laan et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene
X. Cao et al.
GENE THERAPY (2011)
Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma
Rui-Cheng Wei et al.
HUMAN GENE THERAPY (2011)
Systematic review of hepatocellular adenoma in China and other regions
Haoming Lin et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Conformational Changes in Adeno-Associated Virus Type 1 Induced by Genome Packaging
Britta Gerlach et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Recent deal highlights hopes for cancer-killing viruses
Jon Evans
NATURE MEDICINE (2011)
Use of MicroRNA Let-7 to Control the Replication Specificity of Oncolytic Adenovirus in Hepatocellular Carcinoma Cells
Huajun Jin et al.
PLOS ONE (2011)
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Chen Ling et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo et al.
CANCER RESEARCH (2010)
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao et al.
GUT (2010)
The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma
Yigang Wang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24
Yu-mei Wu et al.
ACTA PHARMACOLOGICA SINICA (2009)
Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-β expression driven by hTERT promoter
Ling Feng He et al.
CANCER LETTERS (2009)
Potent antitumor activity of double-regulated oncolytic adenovirus-mediated ST13 for colorectal cancer
De Bin Yu et al.
CANCER SCIENCE (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Potent Antitumor Effect of Interleukin-24 Gene in the Survivin Promoter and Retinoblastoma Double-Regulated Oncolytic Adenovirus
Kang Jian Zhang et al.
HUMAN GENE THERAPY (2009)
Antisense Hypoxia-Inducible Factor-1α Augments Transcatheter Arterial Embolization in the Treatment of Hepatocellular Carcinomas in Rats
Xueying Sun et al.
HUMAN GENE THERAPY (2009)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC
Qiuwei Pan et al.
ACTA ONCOLOGICA (2008)
Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration
Karen J. Ho et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma
Zan Shen et al.
CANCER LETTERS (2008)
Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil
L. Chu et al.
GENE THERAPY (2008)
Adeno-associated virus integration: virus versus vector
R. H. Smith
GENE THERAPY (2008)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
Significant antitumor activity of oncolytic adenovirus expressing human interferon-β for hepatocellular carcinoma
Ling Feng He et al.
JOURNAL OF GENE MEDICINE (2008)
Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma
Yigang Wang et al.
JOURNAL OF GENE MEDICINE (2008)
Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas
Lai Yin Tse et al.
JOURNAL OF GENE MEDICINE (2008)
AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice
Ying Zhang et al.
LIFE SCIENCES (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adeno-associated virus Type 12 (AAV12): A novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity
Michael Schmidt et al.
JOURNAL OF VIROLOGY (2008)
Tissue distribution of cynomolgus adeno-associated viruses AAV10, AAV11, and AAVcy.7 in naturally infected monkeys
S. Mori et al.
ARCHIVES OF VIROLOGY (2008)
AAV vector integration sites in mouse hepatocellular carcinoma
Anthony Donsante et al.
SCIENCE (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer
L. Zhao et al.
CANCER GENE THERAPY (2006)
A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo
Binghua Li et al.
JOURNAL OF GENE MEDICINE (2006)
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
AC Nathwani et al.
BLOOD (2006)
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
M Cardone et al.
HUMAN MOLECULAR GENETICS (2006)
Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector
M Guan et al.
CANCER RESEARCH (2006)
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates
GP Gao et al.
MOLECULAR THERAPY (2006)
被撤回的出版物: Targeting gene-virotherapy of cancer (Retracted Article. See vol 16, pg 740, 2006)
XY Liu et al.
CELL RESEARCH (2006)
Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer
LL Zhao et al.
HUMAN GENE THERAPY (2005)
Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1
ZL Zhang et al.
MOLECULAR THERAPY (2005)
Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver
K Ohashi et al.
HUMAN GENE THERAPY (2005)
Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo
Z Shevtsova et al.
EXPERIMENTAL PHYSIOLOGY (2005)
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice
H Nakai et al.
JOURNAL OF VIROLOGY (2005)
Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein
S Mori et al.
VIROLOGY (2004)
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
CC O'Shea et al.
CANCER CELL (2004)
An oncolytic adenoviral vector of smac increases antitumor activity of TRAIL against HCC in human cells and in mice
ZF Pei et al.
HEPATOLOGY (2004)
An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy
ZL Zhang et al.
CELL RESEARCH (2003)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses
A Kanerva et al.
MOLECULAR THERAPY (2002)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri et al.
NATURE MEDICINE (2000)
Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
BL Davidson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Share Paper
